Many studies have revealed that the inflammatory response plays a key role in the pathophysiology of cerebral ischaemia‒reperfusion injury, and the activation of the HMGB1/TLR4/NF-κB signaling pathway has been found to be involved in cerebral ischemia-induced inflammation [14–17]. This evidence concerns the gene HMGB1 and brain ischemia.